Artelo Biosciences Financial Overview
Artelo Biosciences's market cap is currently $2.13M. The company's EPS TTM is $-3.97; its P/E ratio is -0.10; Artelo Biosciences is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-1.57. See an overview of income statement, balance sheet, and cash flow financials.
